Jonathan B. Rothbard - Sep 4, 2023 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role: Chief Scientific Officer
Signature: /s/ Jonathan B. Rothbard, Ph.D.
Stock symbol: ATNF
Transactions as of: Sep 4, 2023
Transactions value $: $0
Form type: 4
Date filed: 9/8/2023, 04:00 PM
Previous filing: Dec 10, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ATNF	Common Stock						28K	Sep 4, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ATNF	Stock Option (Right to Buy)	Award	$0	+15K		$0.00	15K	Sep 4, 2023	Common Stock	15K	$0.67	Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Stock Options were granted to the Reporting Person pursuant to the Issuer's First Amended and Restated 2022 Omnibus Incentive Plan in consideration for services to be rendered as Chief Scientific Officer. Exempt from Section 16(b) pursuant to Rule 16b-3.
F2	The options vest at the rate of 1/12th of such options ratably on a monthly basis over the following 12 months on the last day of each calendar month (beginning September 30, 2023), subject to the Reporting Person's continued service to the Company on such vesting dates.